2023 annual financial data
Marker Therapeutics 2023 Financial results
Direct answer
Revenue was 3,311,133 USD.
Operating income was -14,581,378 USD and net income was -8,236,814 USD.
Operating cash flow was -16,439,961 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,311,133 USD
- Operating income
- -14,581,378 USD
- Net income
- -8,236,814 USD
- Operating cash flow
- -16,439,961 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Marker Therapeutics financial years